Galectin-2 expression is dependent on the rs7291467 polymorphism and acts as an inhibitor of arteriogenesis

European Heart Journal

Volumn 33, Issue 9, 2012, Pages 1076-1084

  Van Der Laan, Anja M ^a   Schirmer, Stephan H ^a,b   De Vries, Margreet R ^c   Koning, Jasper J ^d   Volger, Oscar L ^d   Fledderus, Joost O ^a   Bastiaansen, Antonius J N M ^c   Hollander, Maurits R ^d   Baggen, Josefien M ^d   Koch, Karel T ^a   Baan, Jan ^a   Henriques, Jos P ^a   Van Der Schaaf, Ren J ^a   Vis, Marije M ^a   Mebius, Reina E ^d   Van Der Pouw Kraan, Tineke C ^d   Quax, Paul H ^c   Piek, Jan J ^a   Horrevoets, Anton J ^d   Van Royen, Niels ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b SAARLAND UNIVERSITY   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Collateral circulation; Coronary artery disease; Galectin 2; Genetic polymorphism; Monocytes

Indexed keywords

BETA INTERFERON; GALECTIN 2; RNA;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

AGED; ANIMALS; CARDIOVASCULAR AGENTS; COLLATERAL CIRCULATION; CORONARY OCCLUSION; FEMALE; GALECTIN 2; HINDLIMB; HUMANS; INTERLEUKIN-4; MALE; MICE; MICE, INBRED C57BL; MIDDLE AGED; MONOCYTES; POLYMORPHISM, GENETIC; RNA, MESSENGER;

EID: 84858297340     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr220     Document Type: Article

References (27)

1. Elsman P, van 't Hof AW, de Boer MJ, Hoorntje JC, Suryapranata H, Dambrink JH, Zijlstra F. Role of collateral circulation in the acute phase of ST-segment-elevation myocardial infarction treated with primary coronary intervention. Eur Heart J 2004;25:854-858.
2. Meier P, Gloekler S, Zbinden R, Beckh S, de Marchi SF, Zbinden S, Wustmann K, Billinger M, Vogel R, Cook S, Wenaweser P, Togni M, Windecker S, Meier B, Seiler C. Beneficial effect of recruitable collaterals: a 10-year follow-up study in patients with stable coronary artery disease undergoing quantitative collateral measurements. Circulation 2007;116:975-983.
3. Pijls NH, Bech GJ, el Gamal MI, Bonnier HJ, De Bruyne B, Van Gelder B, Michels HR, Koolen JJ. Quantification of recruitable coronary collateral blood flow in conscious humans and its potential to predict future ischemic events. J Am Coll Cardiol 1995;25:1522-1528.
4. Werner GS, Ferrari M, Heinke S, Kuethe F, Surber R, Richartz BM, Figulla HR. Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions. Circulation 2003; 107:1972-1977.
5. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, Windecker S, Eberli FR, Meier B. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J Am Coll Cardiol 2001;38: 1872-1878.
6. Bergmann CE, Hoefer IE, Meder B, Roth H, van Royen N, Breit SM, Jost MM, Aharinejad S, Hartmann S, Buschmann IR. Arteriogenesis depends on circulating monocytes and macrophage accumulation and is severely depressed in op/op mice. J Leukoc Biol 2006;80:59-65.
7. Buschmann IR, Hoefer IE, van Royen N, Katzer E, Braun-Dulleaus R, Heil M, Kostin S, Bode C, Schaper W. GM-CSF: a strong arteriogenic factor acting by amplification of monocyte function. Atherosclerosis 2001;159:343-356.
8. Schirmer SH, Buschmann IR, Jost MM, Hoefer IE, Grundmann S, Andert JP, Ulusans S, Bode C, Piek JJ, van Royen N. Differential effects of MCP-1 and leptin on collateral flow and arteriogenesis. Cardiovasc Res 2004;64:356-364.
9. Schirmer SH, Fledderus JO, Bot PT, Moerland PD, Hoefer IE, Baan J Jr, Henriques JP, van der Schaaf RJ, Vis MM, Horrevoets AJ, Piek JJ, van Royen N. Interferon-beta signaling is enhanced in patients with insufficient coronary collateral artery development and inhibits arteriogenesis in mice. Circ Res 2008;102: 1286-1294.
10. Schirmer SH, Bot PT, Fledderus JO, van der Laan AM, Volger OL, Laufs U, Bohm M, de Vries CJ, Horrevoets AJ, Piek JJ, Hoefer IE, van Royen N. Blocking interferon b stimulates vascular smooth muscle cell proliferation and arteriogenesis. J Biol Chem 2010;285:34677-34685.
11. Loser K, Sturm A, Voskort M, Kupas V, Balkow S, Auriemma M, Sternemann C, Dignass AU, Luger TA, Beissert S. Galectin-2 suppresses contact allergy by inducing apoptosis in activated CD8+ T cells. J Immunol 2009;182:5419-5429.
12. Paclik D, Berndt U, Guzy C, Dankof A, Danese S, Holzloehner P, Rosewicz S, Wiedenmann B, Wittig BM, Dignass AU, Sturm A. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J Mol Med 2008;86:1395-1406.
13. Hellingman AA, Bastiaansen AJ, de Vries MR, Seghers L, Lijkwan MA, Löwik CW, Hamming JF, Quax PH. Variations in surgical procedures for hind limb ischaemia mouse models result in differences in collateral formation. Eur J Vasc Endovasc Surg 2010;40:796-803.
14. Hadi AM, Mouchaers KT, Schalij I, Grunberg K, Meijer GA, Vonk-Noordegraaf A, van der Laarse WJ, Beliën JA. Rapid quantification of myocardial fibrosis: a new macro-based automated analysis. Anal Cell Pathol (Amst) 2010;33:257-269.
15. Smyth GK. Limma: linear models for microarray data. In: Gentleman RC, Carey VJ, Dudoit S, Irizarry R, Huber W (eds), Bioinformatics and Computational Biology Solutions Using R and Bioconductor. New York: Springer; 2005, p397-420.
16. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 2004;5:R80.
17. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 2001;17:509-519.
18. Ozaki K, Inoue K, Sato H, Iida A, Ohnishi Y, Sekine A, Sato H, Odashiro K, Nobuyoshi M, Hori M, Nakamura Y, Tanaka T. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-alpha secretion in vitro. Nature 2004;429:72-75.
19. Salatino M, Rabinovich GA. Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview. Methods Mol Biol 2011;677:355-374.
20. Thijssen VL, Poirier F, Baum LG, Griffioen AW. Galectins in the tumor endothelium: opportunities for combined cancer therapy. Blood 2007;110:2819-2827.
21. Sturm A, Lensch M, Andre S, Kaltner H, Wiedenmann B, Rosewicz S, Dignass AU, Gabius HJ. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J Immunol 2004;173:3825-3837.
22. Stabile E, Kinnaird T, la Sala A, Hanson SK, Watkins C, Campia U, Shou M, Zbinden S, Fuchs S, Kornfeld H, Epstein SE, Burnett MS. CD8+ T lymphocytes regulate the arteriogenic response to ischemia by infiltrating the site of collateral vessel development and recruiting CD4+ mononuclear cells through the expression of interleukin-16. Circulation 2006;113:118-124.
23. van Weel V, Toes RE, Seghers L, Deckers MM, de Vries MR, Eilers PH, Sipkens J, Schepers A, Eefting D, van Hinsbergh V, van Bockel JH, Quax PH. Natural killer cells and CD4+ T-cells modulate collateral artery development. Arterioscler Thromb Vasc Biol 2007;27:2310-2318.
24. van Royen N, Piek JJ, Buschmann I, Hoefer I, Voskuil M, SchaperW. Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease. Cardiovasc Res 2001;49:543-553.
25. Li W, Xu J, Wang X, Chen J, Zhang C, Sun K, Hui R. Lack of association between lymphotoxin-alpha, galectin-2 polymorphisms and coronary artery disease: a meta-analysis. Atherosclerosis 2010;208:433-436.
26. Conway RS, Kirk ES, Eng C. Ventricular preload alters intravascular and extravascular resistances of coronary collaterals. Am J Physiol 1988;254:532-541.
27. de Marchi SF, Oswald P, Windecker S, Meier B, Seiler C. Reciprocal relationship between left ventricular filling pressure and the recruitable human coronary collateral circulation. Eur Heart J 2005;26:558-566.